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15 Mesial temporal lobe epilepsy is the most common, intractable seizure disorder in adults. It is
16 associated with an asymmetric pattern of hippocampal neuron loss within the endfolium (hilus
17 andCA3) andCA1,with limitedpathology inextra-hippocampal regions.Wepreviously developed
18 a model of focally-evoked seizure-induced neuronal death using intra-amygdala kainic acid (KA)
19 microinjection and characterized the acute hippocampal pathology. Here, we sought to
20 characterize the full extent of hippocampal and potential extra-hippocampal damage in this
21 model, and the temporal onset of epileptic seizures. Seizure damage assessed at four stereotaxic
22 levels by FluoroJade B staining was most prominent in ipsilateral hippocampal CA3 where it
23 extended from septal to temporal pole. Minor but significant neuronal injury was present in
24 ipsilateralCA1.Extra-hippocampalneuronaldamagewasgenerally limited inextentandrestricted
25 to the lateral septal nucleus, injected amygdala and select regions of neocortex ipsilateral to the
26 seizure elicitation side. Continuous surface EEG recordedwith implanted telemetry units in freely-
27 moving mice detected spontaneous, epileptic seizures by five days post-KA in all mice. Epileptic
28 seizure number averaged 1–4 per day. Hippocampi from epilepticmice 15 days post-KA displayed
29 unilateral CA3 lesions, astrogliosis and increased neuropeptide Y immunoreactivity suggestive of
30 mossy fiber rearrangement. These studies characterize amousemodel of unilateral hippocampal-
31 dominant neuronal damage and short latency epileptogenesis that may be suitable for studying
32 the cell andmolecular pathogenesis of humanmesial temporal lobe epilepsy.
33 © 2008 Elsevier B.V. All rights reserved.
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445 1. Introduction
46 Mesial temporal lobe epilepsy (MTLE) is the most common and
47 intractable seizure disorder in adults (Chang and Lowenstein,
482003; Engel, 2001). The causal factors in the pathogenesis of
49humanMTLE remain unknown. Its most common pathological
50hallmark is asymmetric hippocampal neuron loss within the
51endfolium (hilus and CA3) and CA1, with relative sparing of the
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52 dentate granule neurons and CA2 subfield (Mathern et al., 1997;
53 Meldrum and Bruton, 1992; Najm et al., 2006). Extra-hippocam-
54 pal neuron losswithin cortical regions and amygdala have been
55 reported in some (Du et al., 1993; Hudson et al., 1993; Pitkanen
56 et al., 1998), but not all (Bothwell et al., 2001; Dawodu andThom,
57 2005) clinical studies. Acutely-incurreddamage following status
58 epilepticus (SE) in patients is foundwithin hippocampus, amyg-
59dala, thalamic nuclei and piriform and entorhinal cortices (De-
60Giorgio et al., 1992; Fujikawa et al., 2000).
61Convulsive SE in rodents has beenused extensively tomodel
62seizure-inducedneuronaldeathandMTLEpathology (Morimoto
63et al., 2004). In rats, systemic pilocarpine or kainic acid (KA) are
64most commonly used, but produce bilateral and widespread
65extra-hippocampaldamagewith limitedorvariablehippocampal
Fig. 1 – Hippocampal and cortical injury following seizures evoked by intra-amygdala KA microinjection. Photomicrographs
show representative FluoroJade B (FjB) staining of ipsilateral fields from control and KA-treated mice at 24 h. (A) Staining (4X
lens) in control mice for the hippocampus, cortex and amygdala. Note absence of FjB positive cells. (B) Representative images of
ipsilateral hippocampus from seizure-damaged mice at rostral (AP, −1.22 mm), medial (AP, −1.82) and caudal (AP, −2.92 mm)
levels, respectively. Arrows highlight FjB positive cells. Images in d show higher power views (40X lens) of FjB-positive cells in
CA3 from (left panel) middle and (right panel) caudal levels. (C) Representative images in a show seizure damage in ipsilateral
temporal cortex at medial and caudal levels. Panel b is a higher power image (40X lens) of representative cells at the level of
medial temporal cortex. Scale bars, A, Ba, Ca, 500 μm; Bd, Cb, 50 μm.
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66 pathology (Sloviter, 2005; Sloviteret al., 2007). Incontrast, focally-
67 evoked seizures by electrical stimulation of theperforant path in
68 rats or mice replicate closely the unilateral pathology of MTLE
69 (Harvey and Sloviter, 2005; Kienzler et al., 2006; Sloviter, 1983).
70 Intra-cerebral KA injection offers an alternate approach to
71 focal elicitation of seizures and induction of epileptogenesis.
72 This includes intra-hippocampal KA (Gouder et al., 2003;
73 Vezzani et al., 1999) and evoking SE by intra-amygdala KA
74 microinjection. In the latter case, the seizures produce amainly
75 unilateral hippocampal lesion with limited extra-hippocampal
76 damage (Ben-Ari et al., 1980;Henshall et al., 2002a,b). Thismodel
77 hasbeenadaptedwithsimilar results to cats (Tanakaetal., 1985)
78 and baboons (Menini et al., 1980). Inmice, hippocampal damage
79 is also largely unilateral, with damage to hippocampal CA3 and
80 the hilus andminor cell death in CA1 (Araki et al., 2002; Murphy
81 et al., 2007; Shinoda et al., 2004a). Whether hippocampal
82 pathology extends from septal (dorsal) to temporal (caudal)
83 pole has not been fully explored, nor has the extent of extra-
84 hippocampal damage.
85 Status epilepticus is also an effective experimental approach
86 to trigger epileptogenesis, with spontaneous seizures emerg-
87 ing in the subsequent days or weeks. Characteristic hippocam-
88 pal changes implicated as causative factors include neuronal
89 death, rearrangement of dentate granule neuron axons (mossy
90 fibre sprouting) (Wuarin and Dudek, 1996), astrogliosis (Li et al.,
91 2008) and neurogenesis (Parent et al., 1997). Unilateral intra-
92 amygdala KA microinjection can precipitate epilepsy within
93two weeks in rats and cats (Tanaka et al., 1988, 1985). Intra-
94cerebral recordings in mice three weeks after intra-amygdala
95KA microinjection have shown the insult is epileptogenic,
96with spontaneous seizures originating from the hippocampus
97(Li et al., 2008).
98The purpose of the present study was to characterize the
99extent of hippocampal and extra-hippocampal damage following
100seizures evoked by intra-amygdala KA microinjection in mice,
101and to determine the onset time of subsequent spontaneous
102seizures. Our data show seizure damage in this model is prin-
103cipally unilateral and mainly confined to the hippocampus, and
104that the injury precipitates epilepsy after a short latent period.
105
1062. Results
1072.1. Behavior during seizures evoked by kainic acid
108Mice showed normal activity immediately after KA microinjec-
109tion. Polyspike seizure EEG typically started 5–10 min later, with
110mice showing immobility. Mice began to develop continuous
111seizuresaftera further20min.Theseepisodeswerecharacterized
112by immobility, followed by tail extension (Straub-tail). Whole
113body clonus, head bobbing and rearing and falling (mouse Racine
114scale 6) were also commonly observed. Short periods of tonic–
115clonic seizures with loss of posture and jumping also occurred
116during the seizures.
Fig. 2 – Quantification of seizure damage in ipsilateral hippocampus and cortex. (A) Graphs showmean FjB-positive cell counts
at three stereotaxic levels for (top) CA3, (middle) CA1 and (bottom) hilus, in control (Con) and KA-treated mice (KA) at 24 h.
(B) Graphs show FjB-positive cell counts in temporal, entorhinal and perirhinal cortex at two stereotaxic levels in control and
KA-treated mice. Data are mean±SD from n=4 per group. *p<0.05 versus control.
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117 2.2. Hippocampal damage following intra-amygdala KA
118 microinjection in mice
119 We recently described induction of seizures by intra-amygdala
120 KA microinjection in mice, seizure termination effects of two
121 anticonvulsants and hippocampal injury at the level of the
122 dorsal hippocampus (Shinoda et al., 2004a). In the present study
123 we sought to characterize the extent of hippocampal damage
124 and extra-hippocampal damage resulting from seizures evoked
125 by intra-amygdala KA microinjection, using FluoroJade B (FjB)
126 staining to mark irreversibly damaged cells. Four stereotaxic
127 levels were examined at 24 h, representing the level of KA
128 injection, and the rostral, medial (septal pole) and caudal
129 (temporal pole) extent of the hippocampus.
130 Control mice displayed no significant FjB staining in the
131 hippocampus ipsilateral or contralateral to the side of vehicle
132 injection (Figs. 1A,2A and data not shown). In contrast, mice
133 that received intra-amygdala KA microinjection had promi-
134 nent FjB staining in ipsilateral CA3 at the levels of the rostral,
135 medial and caudal hippocampus (Figs. 1B
^
and 2A). Numbers of
136 FjB-positive CA3 cells in KA-injected mice were significantly
137 higher than controls at each level examined (Fig. 2A). Counts
138 in KA-injected mice were somewhat higher at medial and
139 caudal levels than rostral hippocampus (Fig. 2A). A variable
140 number of FjB-positive cells were present within the hilar
141 region of the dentate gyrus in these mice (Figs. 1B
^
and 2A).
142 All KA-injected mice had small numbers of FjB-positive cells
143 present in ipsilateral CA1 at one ormore of the three hippocampal
144levels studied (Fig. 1B). Counts were only significant compared to
145control at the levelof caudalhippocampus (Fig. 2A).Occasional FjB-
146positive cells were found within contralateral CA1 and CA3 in KA-
147injected mice but numbers were not significant (data not shown).
1482.3. Seizure damage in ipsilateral temporal, entorhinal and
149perirhinal cortices
150Wenext examined damagewithin three cortical regions at levels
151corresponding to the medial and caudal hippocampus. No FjB-
152positive cells were found in vehicle-injected controls (Figs. 1A
^153and 2B). Small but significant numbers of FjB-positive cells were 154present in KA-injected mice in temporal, entorhinal and peri-
155rhinal cortex at the level ofmedial hippocampus (Figs. 1Cand2B).
156Numbers of cortical FjB positive cells at the level of the caudal
157hippocampus were smaller than at the medial level but were
158significant in two of the three cortical regions examined (Fig. 2B).
159No significant FjB staining was found in cortical regions in the
160contralateral hemisphere of KA-injected mice (data not shown).
1612.4. FjB staining in the amygdala and lateral septal nucleus
162As expected, FjB-positive cells were present within the
163ipsilateral amygdala at the level of injection site in both KA-
164injected and control mice (Fig. 4B). Counts of FjB-positive cells
165were significantly higher in KA-injected mice compared to
166controls in the ipsilateral amygdala at levels corresponding to
167rostral and medial hippocampus (Figs. 3A,B and 4B
^
). No FjB-
Fig. 3 – Seizure damage in amygdala, thalamus and lateral septal nucleus. (A) Representative photomicrographs fromKA-treated
mice at 24 h showing FjB stainingwithin a, amygdala at rostral andmedial levels, b lateral septal nucleus (LSN) and c thalamus. LD,
lateral dorsal; VL, ventrolateral; M, medial. (B) Higher power (20× lens) images of FjB-stained cells in a, amygdala, b, lateral septal
nucleus and c,d thalamic nuclei. Scale bars in A, 500 μm; B, 100 μm.
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168 positive cells were present in the contralateral amygdala at
169 any level examined in control or KA-injected mice.
170 Significant FjB staining was detected in all KA-injected
171 mice within the ipsilateral lateral septal nucleus (LSN) at the
172 level of the amygdala injection point (Figs. 3A and 4A). FjB-
173positive cells were present within the contralateral LSN in 50%
174of KA-injected mice (Figs. 3A and 4A).
1752.5. FjB staining in thalamus after seizures
176Finally, we examined FjB staining at the level of the injection
177point and rostral and medial hippocampus, for three thalamic
178nuclei. Occasional scattered FjB-positive cells were present in
179some KA-injected mice in the lateral–dorsal thalamus and
180ventro-lateral thalamus at the level of rostral hippocampus
181(Figs. 3Aand4C,D). Counts of thalamic FjB-positive cells showed
182no significant difference between controls and KA-treatedmice
183and no FjB-positive cells were present in KA-injected mice on
184the contralateral side for any of the thalamic areas at any level.
1852.6. Short latency epileptogenesis following intra-amygdala
186KA microinjection in mice
187The time of onset of spontaneous, recurrent seizures following
188damage caused by intra-amygdala KA microinjection in mice
189has not yet been investigated. To profile epileptogenesis in
190this model we used implantable EEG telemetry units to record
191surface EEG in freely-moving mice. Four mice were subject to
192two weeks of 24 h/day EEG recordings after KAmicroinjection.
193Intermittent EEG recordings from vehicle-injected mice did
194not detect any epileptic seizures (data not shown).
195No mice died after intra-amygdala KA microinjection or
196during long-term recordings, and all mice developed sponta-
197neous seizures (Fig. 5). Epileptic seizures were typically char-
198acterized by a brief period of immobility during onset. This was
199followed by jaw and forelimb clonus and elevated tail (Straub-
200tail). Epileptic seizures typicallyprogressed to rearingand falling
201and inmore severe events included loss of posture and jumping
202(up to Racine scale 6).
203The first day in which a spontaneous seizure was detected
204by surface EEG was day 3 after KA microinjection (1 of 4 mice).
205By day 4 after KA three of four mice had had an epileptic
206seizure, and all mice had displayed an epileptic seizure by day
2075 after KA microinjection (Fig. 5B). From day 4 thereafter, mice
208averaged 1–4 seizures per day (full range 0–10). The average
209electrographic seizure durationwas 20.2±15.1 s (range 10–90 s,
210from 142 captured events). Daily spontaneous seizure rates
211averaged across the group remained relatively consistent over
212the course of the recording period (Fig. 5B). Spontaneous
213seizures for individual mice showed variability between days
214and across the recording period (Fig. 5C).
2152.7. Hippocampal astrogliosis and mossy fiber
216rearrangement in epileptic mice
217Finally, we examined sections from control mice and epileptic
218mice killed on day 15 after the two week EEG recordings post-
219KA, to visualize long-term changes to the hippocampus. NeuN
220immunostaining confirmed the presence of macroscopic ipsi-
221lateral CA3 lesions in epileptic mice (Fig. 6A). These were not
222present on the contralateral side of epileptic mice (Fig. 6A).
223Next, we counter-stained NeuN-labeled sections with anti-
224bodies against glial fibrillary acidic protein (GFAP) as amarker of
225astrogliosis. Examination of GFAP-stained hippocampi in epi-
226leptic mice revealed increased staining in the ipsilateral CA3
Fig. 4 – Quantification of seizure damage in lateral septal
nucleus, amygdala and thalamus. (A) Counts of FjB-positive
cells in control (Con) and seizure mice (KA) within the
ipsilateral (i) and contralateral (c) lateral septal nucleus (LSN).
(B) Counts of FjB-positive cells within the amygdala nucleus at
the level of the injection (inj) point (AP, −0.96mm), rostral (ros)
andmedial (med) levels. (C) Counts of FjB-positive cells in
lateral dorsal (LD) and ventrolateral (VL) at the level of injection
point, rostral hippocampus andmedial hippocampus.Data are
mean±SD for n=4 per group.
5B R A I N R E S E A R C H X X ( 2 0 0 8 ) X X X – X X X
ARTICLE IN PRESS
Please cite this article as: Mouri, G., et al., Unilateral hippocampal CA3-predominant damage and short latency epileptogenesis
after intra-amygdala microinjection of kainic acid in mice, Brain Res. (2008), doi:10.1016/j.brainres.2008.03.061
UN
CO
RR
EC
TE
D
PR
OO
F
227 regionof epilepticmice, and thepresence of thickenedastrocyte
228 processes (Fig. 6B).
229 We also stained sections from epileptic mice for FjB to exa-
230 mine ongoing degenerative changes (Fig. 6C). Hippocampal FjB
231 stainingwas largely negative, althoughone epilepticmousehad
232 a small cluster of FjB-positive cells within ipsilateral CA3 (data
233not shown) (Fig. 6C). A small number of FjB-positive cells (range
2347–58) were also present in ipsilateral cortex in sections from
235epileptic mice (data not shown).
236Last, we undertook immunostaining for neuropeptide Y
237(NPY) on hippocampal sections from epileptic mice, as a surro-
238gate marker of mossy fiber axon rearrangement (Borges et al.,
2392003). Compared to control, there were prominent increases in
240NPY immunoreactivity in ipsilateral hippocampus, including
241mossy fibers throughout the suprapyramidal region of CA3 and
242inner molecular layer of the dentate gyrus (Fig. 6D). While
243asymmetric, increased NPY immunostaining in themossy fiber
244pathway was also apparent in the contralateral hippocampus
245(Fig. 6D).
246
2473. Discussion
248In vivomodels of prolonged seizures have been valuable tools for
249advancing our understanding of the cell and molecular patho-
250genesis of human MTLE (Morimoto et al., 2004). A majority of
251hippocampi obtained frompatients with temporal lobe epilepsy
252display neuropathologic changes that comprise preferential
253unilateral neuron loss within the endfolium and CA1, with rela-
254tive sparing of CA2. Additional features include (astro)gliosis,
255dentate granule cell layer dispersion andmossy fibre rearrange-
256ment (Najm et al., 2006). Limitations exist with some animal
257models in terms of reflecting this pathology. Systemic admin-
258istration of pilocarpine or KA produces bilateral damage that is
259oftenextensive in thecortex,whilehippocampaldamage,where
260present, may be the result of secondary processes such as
261ischemichemorrhage (Fariello et al., 1989; Sloviter, 2005; Sloviter
262et al., 2007). Commonly used mouse strains also lack character-
263istic seizure damage in hippocampus after systemically-deliv-
264ered convulsants (Schauwecker and Steward, 1997). Focal
265elicitation approaches such as electrical stimulation of the per-
266forant path appear to more faithfully model the unilateral and
267hippocampal-predominant neuropathology of human MTLE
268(Harvey and Sloviter, 2005; Kienzler et al., 2006; Sloviter, 1983;
269Sloviter et al., 2007). An alternative approach has been to elicit
270seizures by intra-amygdala KA microinjection. Originally des-
271cribed in rats (Ben-Ari et al., 1980),weadapted thismodel tomice
272(Araki et al., 2002; Shinoda et al., 2004a). While independent
273groupshave subsequently employed themodel inmice (Kasugai
274et al., 2007; Li et al., 2008), the present study provides important
275additional characterization. First, our experiments show
276damage in CA3 spans the full rostro-caudal extent of the ipsi-
277lateral hippocampus and was similar at each level examined.
Fig. 5 – Temporal course of epilepsy emergence after
intra-amygdala KA microinjection using radiotelemetry EEG
in mice. (A) Representative EEG traces showing baseline EEG
and examples of typical epileptic seizures captured by EEG
telemetry (between arrows). Bottom trace shows typical
electrographic seizure onset. (B) Graphs represent (top)
average number of epileptic seizures per day, and (bottom)
cumulative average duration of epileptic seizures per day.
Data are mean±SD for n=4 per group. (C) Graphs showing
daily seizure number and cumulative seizure time for the
individual recorded mice (m).
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278 This supports the injury as seizure-related, rather than a result
279 of diffusion of KA from the injection site. Indeed, the extent of
280 the CA3 lesion can be further restricted by administering
281 lorazepam 30 min after intra-amygdala KA microinjection in
282 thismodel (Li et al., 2008). TheCA2 subfieldwas not damaged by
283 intra-amygdala KA-induced seizures, in agreement with the
284resistance reported previously using this model (Araki et al.,
2852002; Kasugai et al., 2007; Li et al., 2008; Shinoda et al., 2004a).
286Damage to CA1 is often present in humanMTLE and we find as
287before (Araki et al., 2002; Shinoda et al., 2004a), that CA1 injury,
288though not strongly induced, is nonetheless present in mice
289after intra-amygdalaKAmicroinjection, particularly in temporal
Fig. 6 – Chronic hippocampal changes in epileptic mice. Representative photomicrographs of hippocampal changes in the
ipsilateral and contralateral hippocampi of epileptic mice. (A) Photomicrographs showing (top) 4× and (bottom) 20× lens field
views of NeuN immunostaining in hippocampi from control and epileptic mice at day 15. Note the presence of a lesion in
ipsilateral but not contralateral CA3 of epileptic mice (arrow). (B) Representative NeuN/GFAP double immunostaining (20× lens)
in control and epilepticmice. Note elevated GFAP stainingwithin the lesioned region of the ipsilateral CA3. (C,D) Representative
photomicrographs (4× lens) showing FjB and neuropeptide Y (NPY) in control and epilepticmice. Note enhancedNPY staining in
epileptic mice but lack of FjB staining. Scale bar in top left panel in A, C 500 μm; bottom left in A, 100 μm.
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290 hippocampus. Since human MTLE pathology is mainly unilat-
291 eral and affects the hilar, CA3 and CA1 hippocampal subfields,
292 the present study supports the relevance of the modeling ap-
293 proach and species used.
294 Cortical neuronal injury has not previously been investi-
295 gated following intra-amygdala KA microinjection in mice.
296 The present study shows only small numbers of ipsilateral
297 cortical neurons are damaged in this model. This matches
298 similar findings in rats with this model (Henshall et al., 2002),
299 and supports the clinical relevance of the model since cortical
300 neuron loss in human MTLE is typically limited or absent
301 (Bothwell et al., 2001; Dawodu and Thom, 2005; Doherty et al.,
302 2003). The model does not appear to evoke significant damage
303 to the thalamus, which is an area vulnerable in some models
304 (Kubova et al., 2001) and in patients after status epilepticus
305 (Fujikawa et al., 2000). Experimental SE often causes amygdala
306 injury (Nissinen et al., 2000; Tuunanen et al., 1999), and this
307 was seen in the present study, although injury at the rostral
308 extent likely resulted from mechanical (cannula) or direct
309 excitotoxic effects of KA. A limitation of the model lies with
310 achieving complete seizure cessation after intra-amygdala KA
311 microinjection. However, some control is possible through
312 varying anticonvulsant administration time (Araki et al., 2002;
313 Li et al., 2008; Shinoda et al., 2004a). An additional advantage of
314 the present model is its adaptability for use in genetically-
315 modified mice, where it has recently been employed to cha-
316 racterize the anti-apoptotic role of bcl-w (Murphy et al., 2007)
317 and epileptogenic effects of adenosine kinase (Li et al., 2008).
318 A latent period between an initial precipitating neurologi-
319 cal injury and subsequent emergence of epileptic seizures is
320 characteristic of acquired MTLE (Williams et al., 2007). Latent
321 periods of a month or more are typically reported for expe-
322 rimental SE-induced epilepsy (Morimoto et al., 2004; Pitkanen
323 et al., 2007). However, spontaneous seizure onset has been
324 detected in subgroups of animals within a week of SE using
325 both systemic and focal elicitation approaches (Harvey and
326 Sloviter, 2005; Nissinen et al., 2000; Shibley and Smith, 2002).
327 By undertaking continuous EEG recordings we could detect
328 epileptic seizures within 3–4 days of intra-amygdala KA-
329 induced SE, with all tested mice epileptic by day 5. This
330 short latent periodmay result from the localized, reproducible
331 damage in this model and the fidelity of continuous EEG
332 monitoring post-KA (Williams et al., 2007). Our data are con-
333 sistent with awareness that apparently protracted latent
334 periods in some animals or in some models result in part
335 from inter-animal variability, the extent of hippocampal
336 injury after SE or intermittent EEG monitoring (Williams
337 et al., 2007). The short latent period here also implies pro-
338 tracted pathological processes are unlikely responsible for the
339 emergence of spontaneous seizures in the present model.
340 Mossy fiber sprouting has been linked to the formation of
341 epileptic circuits (Dudek et al., 1994; Wuarin and Dudek, 1996)
342 and can precede emergence of spontaneous seizures (Hen-
343 driksen et al., 2001). However, spontaneous seizures occur in
344 post-SE animals without mossy fiber sprouting and the
345 frequency of epileptic events may bear little relation to the
346 extent of sprouting (Nissinen et al., 2000, 2001; Williams et al.,
347 2002). While not excluding a role, the early onset of sponta-
348 neous seizures in the present model probably undermines a
349 significant contribution. Nevertheless, mossy fiber sprouting,
350as implied by NPY immunostaining, was apparent in (epilep-
351tic) mice 15 days after KA. The present study also identified
352astrogliosis within the field of primary damage within the
353hippocampus. This supports work by Li et al. using the same
354model, which implicated overexpression of adenosine kinase
355secondary to astrogliosis in CA3 in epileptic seizure generation
356(Li et al., 2008).
357Neuropeptide Y is an endogenous modulator of excitability
358and potent inhibitor of seizures. Our data show its presence in
359normal hippocampus and elevation in hippocampus of epi-
360leptic mice, in accordance with reports in chronically epileptic
361rodents (Nissinen et al., 2000; Schwarzer et al., 1995; Vezzani
362et al., 1994) and studies showing its elevation in the terminals
363of mossy fibres (Tu et al., 2005; Vezzani et al., 1996). Whether
364increased hippocampal NPY levels influences epileptic sei-
365zures in the present model is unknown, but anticonvulsant
366and seizure-terminating roles are supported by findings in
367mice deficient in NPYwhich display spontaneous seizures and
368have increased sensitivity to kainic acid, effects reversed by
369intracerebral NPY administration (Baraban et al., 1997). Trans-
370genic or viral vector-mediated NPY overexpression in rats also
371reduces seizures, seizure susceptibility and epileptogenesis
372(Richichi et al., 2004; Vezzani et al., 2002; Woldbye et al., 1997).
373However, some data are consistent with seizure-promoting
374actions of NPY (Liu et al., 1999; Vezzani et al., 1994).
375The percentage of animals developing epilepsy after SE
376shows variance according to model and monitoring employed
377(Williams et al., 2007). High rates (~90%) are reported following
378electrical amygdala-stimulation (Nissinen et al., 2000; Pitkanen
379et al., 2005) and all C57Bl/6 mice surviving pilocarpine-induced
380SEbecomeepileptic (Borges etal., 2003;ShibleyandSmith, 2002).
381Inagreementwith findings fromhippocampalEEGrecordings in
382mice three weeks after intra-amygdala KA microinjection (Li
383et al., 2008), we found all mice in our study became epileptic.
384This supports high-reproducibility of epileptogenesis in this
385model. However, variability in outcome may be a desired cha-
386racteristic, for instance for identification of surrogate or bio-
387markers amonganimals subject to the same initial precipitating
388injury.
389Daily epileptic event rates remain quite constant in models
390of amygdala-triggered SE (Nissinen et al., 2000), although the
391proportion of partial versus secondarily generalized seizures
392may change (Nissinen et al., 2000; Tanaka et al., 1988). Inter-
393animal differences in daily event number were found in the
394present model, but when averaged across the group the daily
395seizure frequency remained quite consistent once epilepsy
396emerged. Epileptic seizure durations found in our model were
397on average of shorter duration than those reported after elec-
398trical stimulation of the amygdala (Nissinen et al., 2000; Pit-
399kanen et al., 2007). Since damagewas bi-lateral in the studies of
400Nissinen et al., this supports the influence of the extent of
401damage and regions affected in the epileptic phenotype.
402A relationship between the duration or intensity of SE as the
403initial precipitating injury and subsequent epileptic phenotype
404has been demonstrated (Klitgaard et al., 2002; Nissinen et al.,
4052000; Pitkanen et al., 2005).Moreover, a critical threshold of hilar
406interneuron lossmay be theminimal substrate for formation of
407epileptic circuits (Zappone and Sloviter, 2004). Taken together,
408our data are consistent with relatively restricted and unilateral
409hippocampalneuronaldeathbeingsufficient for epileptogenesis.
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410 Interestingly,mice subject to intra-amygdala KAmicroinjection
411 that have a lesion restricted to ipsilateral CA3a display
412 hippocampal-only seizures (Li et al., 2008). Monitoring in that
413 study was only during a single day three weeks post-KA and so
414 may have missed some secondarily generalized events. Never-
415 theless, these data suggest damage in addition to CA3a under-
416 lies the expression of seizures we detected on surface EEG.
417 Preventing neuronal death by primary (e.g. glutamate antago-
418 nists) or secondary (downstream cell death signaling pathways)
419 neuroprotective agents may therefore be critical to blocking or
420 mitigating epilepsy after SE (Meldrum, 2002). However, results
421 from some studies challenge the efficacy of either class of
422 neuroprotectant as an approach to anti-epileptogenesis (Brandt
423 et al., 2003; Narkilahti et al., 2003).
424 In conclusion, the present study provides a more complete
425 characterization of the acute hippocampal and extra-hippo-
426 campal damage incurred by seizures after intra-amygdala KA
427 microinjection in mice. The pattern of damage reflects that
428 common tohumanMTLEand the injury elicits epilepsywithin a
429 short latent period. Accordingly, intra-amygdala KAmicroinjec-
430 tion in mice may provide a suitable means for modeling the
431 pathogenesis of MTLE and studying its genetic architecture.
432
433 4. Experimental procedures
434 4.1. Seizure model
435 Animal experiments were carried out in accordance with the
436 principals of the European Communities Council Directive (86/
437 609/EEC) and National Institute of Health's Guide for the Care and
438 Use of LaboratoryAnimals.Procedureswere reviewedandapproved
439 by the Research Ethics Committee of the Royal College of Sur-
440 geons in Ireland, under license from the Department of Health,
441 Dublin, Ireland.
442 Studies were performed according to previously described
443 techniques (Murphy et al., 2007; Shinoda et al., 2004a). Mice
444 (C57BL/6adultmale, 20–25g)wereobtained fromHarlan,UK.Mice
445 were anesthetized using isoflurane (3–5%) and maintained nor-
446 mothermic by means of a feedback-controlled heat blanket
447 (Harvard Apparatus Ltd, Kent, England). A catheter was inserted
448 into the femoral vein for administration of anticonvulsant. Mice
449 were next placed in a stereotaxic frame and following a midline
450 scalp incision three partial craniectomies were performed and
451 mice were affixed with cortical electrodes (Bilaney Consultants
452 Ltd, Sevenoaks, UK) to record surface EEG. Electrodeswere placed
453 above dorsal hippocampus and a third over frontal cortex. EEG
454 was recorded using a Grass Comet digital EEG (Medivent Ltd,
455 Lucan, Ireland). A guide cannula was affixed (coordinates from
456 Bregma: AP=−0.94; L=−2.85 mm) (Franklin and Paxinos, 1997)
457 and the entire skull assembly fixed in place with dental cement.
458 Anesthesia was then discontinued and freely moving mice were
459 placed in a clear Perspex recording chamber. EEG recordingswere
460 commencedandafter establishingbaselineEEGfor a fewminutes
461 mice were lightly restrained by the experimenter to permit lowe-
462 ringofan injectioncannula through theguidecannula to3.75mm
463 below the dura for microinjection of KA (Ocean Produce Interna-
464 tional, Nova Scotia, Canada) (0.3 μg in 0.2 μl phosphate-buffered
465 saline, PBS) into the basolateral amygdala nucleus. Non-seizure
466 controlmice receivedthesamevolumeof intra-amygdalavehicle.
467Forty minutes following microinjection of KA or vehicle, mice
468received intravenous lorazepam(6mg/kg) and theEEGmonitored
469for up to 1 h thereafter. Administration of lorazepamwas used to
470curtail status epilepticus, thereby reducing mortality, morbidity
471and restricting the extent of damage, as described previously
472(Shinoda et al., 2004a). Mice were euthanized 24 h following lora-
473zepam and perfused with saline to remove intravascular blood
474components. Brains were flash-frozen whole in 2-methylbutane
475at −30 °C and processed for histopathology as described below.
4764.2. Analysis of spontaneous seizures using EEG telemetry
477A separate group of mice were subject to long-term EEG
478monitoring to detect the emergence of spontaneous seizures.
479For these purposes, EEG was recorded using implantable EEG
480telemetry units (Data Systems International, St. Paul, MN) ac-
481cording to previously reported techniques with modifications
482(Weiergraber et al., 2005). EEG data were acquired using the
483Dataquest A.R.T. system with EEG transmitters (Model: F20-
484EET, DSI) configured to record 2 channel EEG that were affixed
485over dorsal hippocampi/temporal cortex under anesthesia.
486Transmitter units were placed in a subcutaneous pocket along
487the dorsal flank. Following surgery and KA-induced seizures,
488units were activated and telemetry recordings commenced for
48914 days from cages on top of receivers (RPC-1), thus allowing
490free movement and access to food and water. Continuous EEG
491data was transferred to a PC via a Data Exchange Matrix (DSI).
492Mice were euthanized on day 15 and brains processed for
493histopathology and immunostaining as described above. Tele-
494metry EEG recordings were manually analyzed with epileptic
495seizures defined according to Pitkanen et al. (Pitkanen et al.,
4962005) as high frequency (N5 Hz) high amplitude (N2 baseline)
497polyspike discharges of ≥5 s duration.
4984.3. Behaviour
499MicewereobservedduringKA-induced seizures andalso during
500spontaneous epileptic seizures and scored according to amodi-
501fied Racine scale for mice (Borges et al., 2003). Score 0, normal
502activity; Score 1, arrest and rigid posture or immobility; Score 2,
503stiffened or extended tail; Score 3, partial body clonus, including
504forelimb clonus or head bobbing; Score 4, rearing; Score 5, rea-
505ring and falling; Score 6 tonic–clonic seizures with loss of pos-
506ture or jumping.
5074.4. Histopathology
508Brains were sectioned at 12 μm on a Leica cryostat at four
509stereotaxic levels (AP fromBregma; −0.94mm (injection point),
510−1.22 mm (rostral hippocampus), −1.82 mm (medial hippo-
511campus) and −2.92 mm (caudal hippocampus)) according to a
512mouse stereotaxic atlas (Franklin and Paxinos, 1997). Brain
513regions studied were ipsilateral and contralateral to injection
514side as follows: lateral septal nucleus, basolateral amygdala,
515hippocampal hilus, CA3 and CA1, temporal cortex, entorhinal
516cortex, perirhinal cortex, piriform cortex, lateral–dorsal thala-
517mus, medio-dorsal thalamus and ventro-lateral thalamus.
518Neuronal damage was assessed using the FluoroJade B (FjB)
519technique. Briefly, sectionswere air-dried and post-fixed in 10%
520formalin.Next, sectionswere immersed in100%ethanol (3min),
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521 followed by immersion in 70% ethanol (1 min) then rinsed in
522 distilled water (1 min). Sections were next transferred to fresh
523 0.006%potassiumpermanganatesolution for15minwithgentle
524 shaking. Sections were then rinsed again and transferred to FjB
525 solution (0.001% in 0.1% acetic acid) (Chemicon Europe Ltd,
526 Chandlers Ford, UK). After staining, sections were rinsed again,
527 dried, cleared and mounted in DPX (Sigma-Aldrich). Sections
528 wereexaminedusingaNikon2000sepifluorescencemicroscope
529 (Micro-optica,Dublin, Ireland) under Ex/Emwavelengthsof 330–
530 380/420 nm (blue), 472/520 nm (green) and 540–580/600–660 nm
531 (red) and imaged using a Hamamatsu Orca 285 camera. Pseudo-
532 colour transforms from monochromatic Hamamatsu Orca 285
533 images were undertaken using Adobe® Photoshop® 6.0. FjB
534 positive cells were the average of two adjacent sections counted
535 by an observer blinded to experimental treatment (Shinoda
536 et al., 2004a,b).
537 4.5. Immunohistochemistry
538 Immunohistochemistrywasundertakenaccording topreviously
539 described techniques (Murphy et al., 2007). Briefly, fresh-frozen
540 sections (12 μm) were air-dried, post-fixed in 10% formalin and
541 washed in PBS. Next, sections were permeabilized with 0.3%
542 Triton X-100 and blocked in 5% goat serum for 1 h. Sectionswere
543 then incubated overnight with antibodies against NeuN (Che-
544 micon) or GFAP (Sigma-Aldrich) (both 1:500), or neuropeptide Y
545 (NPY, 1:1000) (Sigma-Aldrich), were washed again in PBS and
546 incubated in goat anti-mouse AlexaFluor 568 (for NeuN and
547 GFAP) and goat anti-rabbit AlexaFluor 488 (for NPY) (Bio Sciences
548 Ltd, Dun Laoghaire, Ireland). Sections were mounted with me-
549 dium containing 4′,6 diamidino-2-phenylindole (DAPI) (Vector
550 Laboratories Ltd, Peterborough, UK) to visualize nuclei and
551 fluorescence immunostaining examined as described above.
552 4.6. Statistical analysis
553 Data are presented as mean±SD. Comparison of data was
554 performed using a Mann–Whitney U test and significance was
555 accepted at p<0.05.
556
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